Shalby (SHALBY) Fundamentals 2026 — P/E 50.1x, Revenue Analysis | SniperIQ
Shalby (SHALBY) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹1,757 Crore, trading at ₹163.77 on the NSE. This SniperIQ fundamentals page covers Shalby's valuation (P/E 50.1x, P/B 1.7x), profitability (net margin 3.3%), revenue (₹1,141 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shalby's market cap?
Shalby (SHALBY) has a market capitalization of approximately ₹1,757 Crore, trading at ₹163.77 on the NSE. Market cap moves with the live share price.
What is Shalby's P/E ratio?
Shalby's trailing twelve-month P/E ratio is 50.1x, with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shalby?
Shalby runs a net profit margin of 3.3%, a gross margin of 29.2%, and an operating margin of 6.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shalby generate?
Shalby reported revenue of ₹1,141 Crore for fiscal year 2026, with net income of ₹37 Crore and earnings per share (EPS) of 3.23. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shalby pay a dividend?
Shalby does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Shalby financially healthy?
Shalby carries a debt-to-equity ratio of 0.59x and a current ratio of 1.25x, with a market beta of 0.56. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shalby a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shalby (SHALBY) the key facts are: market cap ₹1,757 Crore, P/E 50.1x, revenue ₹1,141 Crore, 52-week range 125.82-274.7. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shalby's full fundamentals live
Get Shalby's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.